K-877, a SPPARMα, improves the proatherogeniclipid profile of hypertriglyceridaemic patients - even when on stable statin therapy
Presentation prepared and held by Dr Børge G Nordestgaard (Copenhagen, Danmark) in Clinical Breakthroughs: A plethora of new therapeutic targets, Sunday, May 24, 2015 during ISA2015 (Amsterdam, The Netherlands).
To view slides, click on images
K_877_in_hyperTG_Nordestgaard.pdf (1,2MB)
To view slides, click on images
K_877_in_hyperTG_Nordestgaard.pdf (1,2MB)
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: